Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients.

Multiple sclerosis automatic new lesion detection convolutional neural network demyelination disease activity magnetic resonance imaging

Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 4 12 2021
medline: 14 6 2022
entrez: 3 12 2021
Statut: ppublish

Résumé

Active (new/enlarging) T2 lesion counts are routinely used in the clinical management of multiple sclerosis. Thus, automated tools able to accurately identify active T2 lesions would be of high interest to neuroradiologists for assisting in their clinical activity. To compare the accuracy in detecting active T2 lesions and of radiologically active patients based on different visual and automated methods. One hundred multiple sclerosis patients underwent two magnetic resonance imaging examinations within 12 months. Four approaches were assessed for detecting active T2 lesions: (1) conventional neuroradiological reports; (2) prospective visual analyses performed by an expert; (3) automated unsupervised tool; and (4) supervised convolutional neural network. As a gold standard, a reference outcome was created by the consensus of two observers. The automated methods detected a higher number of active T2 lesions, and a higher number of active patients, but a higher number of false-positive active patients than visual methods. The convolutional neural network model was more sensitive in detecting active T2 lesions and active patients than the other automated method. Automated convolutional neural network models show potential as an aid to neuroradiological assessment in clinical practice, although visual supervision of the outcomes is still required.

Sections du résumé

BACKGROUND
Active (new/enlarging) T2 lesion counts are routinely used in the clinical management of multiple sclerosis. Thus, automated tools able to accurately identify active T2 lesions would be of high interest to neuroradiologists for assisting in their clinical activity.
OBJECTIVE
To compare the accuracy in detecting active T2 lesions and of radiologically active patients based on different visual and automated methods.
METHODS
One hundred multiple sclerosis patients underwent two magnetic resonance imaging examinations within 12 months. Four approaches were assessed for detecting active T2 lesions: (1) conventional neuroradiological reports; (2) prospective visual analyses performed by an expert; (3) automated unsupervised tool; and (4) supervised convolutional neural network. As a gold standard, a reference outcome was created by the consensus of two observers.
RESULTS
The automated methods detected a higher number of active T2 lesions, and a higher number of active patients, but a higher number of false-positive active patients than visual methods. The convolutional neural network model was more sensitive in detecting active T2 lesions and active patients than the other automated method.
CONCLUSION
Automated convolutional neural network models show potential as an aid to neuroradiological assessment in clinical practice, although visual supervision of the outcomes is still required.

Identifiants

pubmed: 34859704
doi: 10.1177/13524585211061339
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1209-1218

Auteurs

Alex Rovira (A)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Juan Francisco Corral (JF)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Cristina Auger (C)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Sergi Valverde (S)

TensorMedical, Girona, Spain/Department of Computer Architecture and Technology, University of Girona, Girona, Spain.

Angela Vidal-Jordana (A)

Department of Neurology and Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain/Clinical Neuroimmunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Arnau Oliver (A)

Department of Computer Architecture and Technology, University of Girona, Girona, Spain.

Andrea de Barros (A)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain.

Yiken Karelys Ng Wong (YK)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain.

Mar Tintoré (M)

Department of Neurology and Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain/Clinical Neuroimmunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Deborah Pareto (D)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.

Francesc Xavier Aymerich (FX)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain/Automatic Control Department, Universitat Politècnica de Catalunya BarcelonaTech, Barcelona, Spain.

Xavier Montalban (X)

Department of Neurology and Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain/Clinical Neuroimmunology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Xavier Lladó (X)

Department of Computer Architecture and Technology, University of Girona, Girona, Spain.

Juli Alonso (J)

Neuroradiology Section, Department of Radiology (IDI), Vall d'Hebron University Hospital, Barcelona, Spain/Neuroradiology Research Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain/Universitat Autònoma de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH